| | | | Index Performance | | Index | Sensex | Nifty | | Open | 13,067.08 | 4,039.30 | | High | 13,067.08 | 4,040.70 | | Low | 12,605.00 | 3,835.50 | | Today's Cls | 12,676.19 | 3,861.10 | | Prev Cls | 13,330.51 | 4,039.70 | | Change | -654.32 | -178.60 | | % Change | -4.91 | -4.42 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | IFCI | 37.90 | 0.66 | | Tech Mahindra | 670.70 | 0.64 | | ABG Shipyard | 327.20 | 0.46 | | Bhushan Steel | 843.00 | 0.32 | | Aban Offshore | 2,757.25 | 0.17 | | Losers | | Ranbaxy Lab | 409.25 | -14.01 | | IVRCL Infra | 262.00 | -12.59 | | HDFC Bank | 916.40 | -11.26 | | Tata Chemicals | 276.95 | -10.17 | | Chambal Fertilisers | 59.65 | -10.03 | | | Market Statistics | | - | BSE | NSE | | Advances | 535 | 151 | | Declines | 2,105 | 1,047 | | Unchanged | 57 | 26 | | Volume(Nos) | 24.09cr | 44.53cr | | | | | | Market Commentary | | | Market battered | | Across-the-board selling pressure led by weak banking stocks saw the Sensex shed 4.91%. | | Correction continued for the fourth consecutive session on weak global indices. Dwindling foreign fund inflows into the domestic markets in the past few sessions also adversely affected the sentiment. | 
| | | After shedding around 400 points by mid-morning, the market remained in negative territory, but came close to erasing its losses in the afternoon. However, the mood turned extremely bearish as widespread selling in banking, realty, fast moving consumer goods and metal stocks dragged the index below the 12,650 mark to an intra-day low of 12,605. The Sensex finally managed to pare some of its losses and close at 12,676, down 654 points. The broad-based Nifty closed at 3,861, down 179 points. The breadth of the market was extremely negative with the losers outpacing the gainers. Of the 2,697 stocks traded on the BSE, 2,105 stocks declined, 535 stocks advanced and 57 stocks remained unchanged. All the sectoral indices on the BSE were hammered. The BSE Bankex was the worst hit and tanked 7.75% at 5,508 followed by the BSE Realty index (down 5.44% at 4,503), the BSE CG index (down 5.25% at 10,740) and the BSE Metal index (down 5.21% at 12,226). All the Sensex stocks bore the brunt of heavy selling. Ranbaxy Laboratories led the slump and crashed 14.01% at Rs409.25. Among the other major laggards, HDFC Bank tumbled 11.26% at Rs916.40, ICICI Bank dropped 8.72% at Rs529.30, Hindalco slumped 8.30% at Rs138.10, Reliance Communications fell 7.22% at Rs406.10, HDFC declined 6.86% at Rs1,800.30, BHEL lost 6.66% at Rs1,372.05 and Wipro shed 6.54% at Rs377.95. Other major front-line stocks shed 3-6% each. Banking stocks lost significantly on relentless selling. Yes Bank dropped 9.10% at Rs107.40, UBI shed 7.65% at Rs103.85, SBI tumbled 6.35% at Rs1,177.80 and Axis Bank declined 6.17% at Rs596.55. Kotak Bank, Bank of India, Oriental Bank and Indian Overseas shed 4-6% each. | | | | | | | | European Indices at 16:15 IST on 15-07-2008 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 5178.70 | -121.70 | -2.30 | | CAC 40 Index | 4040.12 | -102.41 | -2.47 | | DAX Index | 6057.11 | -143.14 | -2.31 | | | | | | | | | | | Asian Indices at close on 15-07-2008 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 12754.56 | -255.60 | -1.96 | | Hang Seng Index | 21174.77 | -839.69 | -3.81 | | Kospi Index | 1509.33 | -49.29 | -3.16 | | Straits Times Index | 2830.75 | -73.37 | -2.53 | | Jakarta Composite Index | 2214.85 | -44.68 | -4.91 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
